Drivers of Precision Medicine: Liquid Biopsy and Next-Generation Sequencing
Open Access
- 6 January 2017
- journal article
- Published by MedCrave Group Kft. in Journal of Cancer Prevention & Current Research
- Vol. 7 (1) , 1-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Comparison of high resolution melting analysis, pyrosequencing, next generation sequencing and immunohistochemistry to conventional Sanger sequencing for the detection of p.V600E and non-p.V600E BRAFmutationsBMC Cancer, 2014
- Liquid biopsy: monitoring cancer-genetics in the bloodNature Reviews Clinical Oncology, 2013
- Comparison of Testing Methods for the Detection of BRAF V600E Mutations in Malignant Melanoma: Pre-Approval Validation Study of the Companion Diagnostic Test for VemurafenibPLOS ONE, 2013
- Next Generation Sequencing and Sequence Assembly2013
- A Commercial Real-Time PCR Kit Provides Greater Sensitivity than Direct Sequencing to Detect KRAS MutationsThe Journal of Molecular Diagnostics, 2010
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- Activating and resistance mutations of EGFR in non-small-cell lung cancer: role in clinical response to EGFR tyrosine kinase inhibitorsOncogene, 2009
- BreakDancer: an algorithm for high-resolution mapping of genomic structural variationNature Methods, 2009
- The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATPProceedings of the National Academy of Sciences, 2008
- KRASMutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung CancerClinical Cancer Research, 2007